About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CPC in Adult Refractory Glaucoma | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT04921098

CPC in Adult Refractory Glaucoma

The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.

Lead sponsor: Sohag University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Mina A Besada, Resident

CONTACT

01280899267 mena011205@med.sohag.edu.eg

Ismail M Abdellatif, Professor

CONTACT

Sponsors

Lead Sponsor

Sohag University

A hospital -based, prospective interventional non comparative case series study.This study will be conducted on patients with refractory glaucoma whose ages are 18 years and older.They will be subjected to Transscleral Diode Laser Cyclophotocoagulation. Postoperative evaluation will be scheduled for the first day postoperative, then 1 week later and then at 1st, 3rd, month postoperative.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Patients with refractory glaucoma aging 18 years and older.
•2. Both sexes are included.
•3. Patients Capable of giving informed consent.
•4. Pseudophkic glaucoma.
•5. Aphakic glaucoma.
•6. Silicon oil induced glaucoma.
•7. Neovascular glaucoma.
•8. Inflammatory glaucoma.

Exclusion Criteria

•1. Patients \<18 years of age.
•2. Patients controlled on regular antiglaucomatous therapy.
•3. Patients who cannot do regular follow up visits.
•4. Diffuse scleral staphyloma at the site of CPC.

Related studies

MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma.

NCT05521334 · Refractory Glaucoma

Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma

NCT05437614 · Treatment of Refractory Glaucoma

Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma

NCT01128699 · Refractory Glaucoma

UNKNOWNPhase 1/2

Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma

NCT00349414 · Advanced Glaucoma, Refractory Glaucoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 11, 2022Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment25

Start dateJul 2021

Last updatedJan 11, 2022

Condition

Refractory Glaucoma

Locations shown

Sohag University

Sohag

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions